[HTML][HTML] COVID-19, modern pandemic: a systematic review from front-line health care providers' perspective

M Balla, GP Merugu, M Patel, NM Koduri… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused infection in 168,000 cases
worldwide in about 148 countries and killed more than 6,610 people around the world as of …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis

MS Kim, MH An, WJ Kim, TH Hwang - PLoS medicine, 2020 - journals.plos.org
Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …

COVID-19 therapeutics

D Focosi, M Franchini, F Maggi… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID‐19 (SARS‐CoV‐2) pandemic

D Kheirabadi, F Haddad… - Journal of medical …, 2021 - Wiley Online Library
Background This critical appraisal aims to clarify which systematic reviews on COVID‐19
treatment are based on high‐value evidence. Hereby, the most profitable medicines can be …

[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …

Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications

AR Abubakar, IH Sani, B Godman… - Infection and drug …, 2020 - Taylor & Francis
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

[HTML][HTML] COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus

H Jan, S Faisal, A Khan, S Khan, H Usman, R Liaqat… - Discoveries, 2020 - ncbi.nlm.nih.gov
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19

A Desai, B Gyawali - EClinicalMedicine, 2020 - thelancet.com
Studies to identify potential drugs effective in treating the coronavirus disease 2019 (COVID-
19) are currently ongoing at a rapid pace, although no drug has yet shown improved …